NCT06840366

Brief Summary

This study analyzes the effectiveness of a motor rehabilitation program in the functional recovery of stroke patients and its impact physiotherapy, occupational therapy, and neuropsychology are used to measure improvements in balance, mobility, independence in daily activities, and cognitive functions. The intervention involves the use of the Lokomat, a technologically advanced robot-assisted gait training device. Patients are supported in a harness on a treadmill while the robotic system guides their legs through a natural gait cycle. The results will help clarify the relationship between motor recovery and overall well-being, providing evidence to optimize therapeutic strategies for stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 21, 2025

Completed
20 days until next milestone

Study Start

First participant enrolled

March 13, 2025

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2025

Completed
Last Updated

August 20, 2025

Status Verified

August 1, 2025

Enrollment Period

7 days

First QC Date

February 17, 2025

Last Update Submit

August 14, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Balance

    The Berg Scale is a widely used tool for assessing static and dynamic balance in adults with neuromotor impairments. It consists of 14 items that assess various functional tasks, such as standing, transferring, trunk rotation, and turning gait. Each item is scored on an ordinal scale from 0 to 4, with 0 indicating the lowest functional capacity and 4 indicating independent and safe performance of the task, with a maximum total score of 56 points. Scores below 45 are associated with an increased risk of falls. This scale has demonstrated high interobserver reliability (ICC \> 0.95) and concurrent validity in stroke patients.

    Up to twelve weeks

  • Postural Control

    The Postural Assessment Scale for Stroke Patients (PASS) is specifically designed to assess postural control in stroke patients, both in the acute and chronic phases. It includes 12 items that assess postural maintenance and changes in different positions (recumbent, sitting, and standing). Each item is scored from 0 to 3, with a maximum total score of 36 points. The PASS is particularly sensitive for detecting small functional changes during the early stages of post-stroke recovery and has demonstrated good discriminative and predictive validity for the evolution of postural control and gait. Its use is recom-mended for monitoring clinical progress in the rehabilitation setting.

    Up to twelve weeks

  • Functional Independence

    The Barthel Index is a commonly used instrument for measuring functional inde-pendence in basic activities of daily living (BADL). It assesses a patient's ability to perform 10 activities, including feeding, dressing, toileting, mobility, and climbing and descending stairs, among others. Scoring varies by task, with a maximum of 100 points awarded, with higher scores indicating greater autonomy. The BI is sensitive to clinical changes after rehabilitation interventions and has high reliability (α \> 0.90). It is widely used in clinical research with neurological populations, including post-stroke patients.

    Up to twelve weeks

Study Arms (1)

Lokomat Group

EXPERIMENTAL

The intervention group will be composed of patients who have suffered a stroke and have alterations in mobility, balance and gait. These patients will be selected according to inclusion criteria such as clinical stability and ability to participate in a rehabilitation program. The group will receive structured physiotherapy sessions with a progressive approach to improve postural control, muscle strength, coordination and functional independence.

Other: Lokomat intervention

Interventions

The intervention will consist of an 8-week motor rehabilitation program, with 3 weekly sessions of 60 minutes each. In the first weeks, joint mobilization and postural control in a sitting position will be worked on, followed by muscle strengthening and balance re-education in a standing position. Subsequently, coordination exercises and assisted walking on different surfaces will be incorporated. In the final phase, independent walking and the integration of functional movements in daily life activities will be encouraged. The program will be adapted to the individual needs of each patient to optimize recovery and improve quality of life.

Lokomat Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed diagnosis of ischemic or hemorrhagic stroke.
  • Age equal to or greater than 18 years.
  • Patients in the subacute or chronic phase of stroke (≥ 3 months since the event).
  • Ability to participate in a motor rehabilitation program.
  • Absence of advanced neurodegenerative diseases that may interfere with the evaluation of results.
  • Ability to understand and follow basic instructions of the rehabilitation program.
  • Informed consent signed by the patient or his/her legal representative.

You may not qualify if:

  • People under 60 years of age.
  • Presence of serious comorbidities that prevent physical activity or rehabilitation (e.g. severe heart failure, advanced chronic obstructive pulmonary disease).
  • Patients with severe cognitive impairments that make it difficult to follow the program (e.g. advanced dementia).
  • Use of drugs that significantly affect motor and cognitive function, interfering with the evaluation of rehabilitation.
  • Presence of active infections or unstable medical conditions requiring hospitalization.
  • History of another neurological disorder that may affect functional recovery (e.g. Parkinson's disease, multiple sclerosis).
  • Participation in another rehabilitation program at the same time, which may interfere with the results of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Agustín Aibar Almazán

Jaén, Spain

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 17, 2025

First Posted

February 21, 2025

Study Start

March 13, 2025

Primary Completion

March 20, 2025

Study Completion

May 17, 2025

Last Updated

August 20, 2025

Record last verified: 2025-08

Locations